首页> 美国卫生研究院文献>Molecules >Synthesis and Antifungal Potential of Some Novel Benzimidazole-134-Oxadiazole Compounds
【2h】

Synthesis and Antifungal Potential of Some Novel Benzimidazole-134-Oxadiazole Compounds

机译:新型苯并咪唑-134-恶二唑化合物的合成及抗真菌潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Discovery of novel anticandidal agents with clarified mechanisms of action, could be a rationalist approach against diverse pathogenic fungal strains due to the rise of resistance to existing drugs. In support to this hypothesis, in this paper, a series of benzimidazole-oxadiazole compounds were synthesized and subjected to antifungal activity evaluation. In vitro activity assays indicated that some of the compounds exhibited moderate to potent antifungal activities against tested Candida species when compared positive control amphotericin B and ketoconazole. The most active compounds >4h and >4p were evaluated in terms of inhibitory activity upon ergosterol biosynthesis by an LC-MS-MS method and it was determined that they inhibited ergosterol synthesis concentration dependently. Docking studies examining interactions between most active compounds and lanosterol 14-α-demethylase also supported the in vitro results.
机译:由于对现有药物的耐药性上升,发现具有明确作用机理的新型抗候选药物可能是针对各种致病性真菌菌株的理性方法。为支持这一假设,本文合成了一系列苯并咪唑-恶二唑化合物,并进行了抗真菌活性评估。体外活性测定表明,与阳性对照两性霉素B和酮康唑相比,某些化合物对受试念珠菌具有中等至有效的抗真菌活性。通过LC-MS-MS方法评估了活性最高的化合物> 4h 和> 4p 对麦角固醇生物合成的抑制活性,并确定它们可抑制麦角固醇合成浓度。对接研究大多数活性化合物与羊毛甾醇14-α-脱甲基酶之间的相互作用的研究也支持了体外结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号